rs724159960
Variant summary
Our verdict is Uncertain significance. Variant got 5 ACMG points: 5P and 0B. PM2PP3_ModeratePP5
The ENST00000255078.8(IGHMBP2):c.1582G>A(p.Ala528Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000753 in 1,460,534 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. A528A) has been classified as Likely benign.
Frequency
Consequence
ENST00000255078.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IGHMBP2 | NM_002180.3 | c.1582G>A | p.Ala528Thr | missense_variant | 11/15 | ENST00000255078.8 | NP_002171.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IGHMBP2 | ENST00000255078.8 | c.1582G>A | p.Ala528Thr | missense_variant | 11/15 | 1 | NM_002180.3 | ENSP00000255078 | P1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.00000807 AC: 2AN: 247718Hom.: 0 AF XY: 0.00000746 AC XY: 1AN XY: 134124
GnomAD4 exome AF: 0.00000753 AC: 11AN: 1460534Hom.: 0 Cov.: 31 AF XY: 0.00000688 AC XY: 5AN XY: 726390
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not provided Pathogenic:1Uncertain:1
Likely pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | May 01, 2023 | IGHMBP2: PM3:Strong, PM2 - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Oct 21, 2019 | Not observed at a significant frequency in large population cohorts (Lek et al., 2016); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; This variant is associated with the following publications: (PMID: 25439726, 26752306, 26922252) - |
Charcot-Marie-Tooth disease axonal type 2S Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Nov 06, 2014 | - - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 15, 2021 | The p.A528T variant (also known as c.1582G>A), located in coding exon 11 of the IGHMBP2 gene, results from a G to A substitution at nucleotide position 1582. The alanine at codon 528 is replaced by threonine, an amino acid with similar properties. This variant was detected in two siblings with Charcot-Marie-Tooth disease (CMT) who also had another variant in IGHMBP2; it was not clear whether the variants were in cis or in trans (Cottenie E et al. Am J Hum Genet, 2014 Nov;95:590-601). This variant was also detected in another individual with CMT, but clinical details were limited (Lupo V et al. J Mol Diagn, 2016 Mar;18:225-34). This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at